Introduction COVID-19 cases are on surge; however, there is no efficient treatment or
vaccine that can be used for its management. Numerous clinical trials are being reviewed for …

Aim: COVID-19 is currently the biggest threat to mankind. Recently, ivermectin (a US FDA-
approved antiparasitic drug) has been explored as an anti-SARS-CoV-2 agent. Herein, we …

The broad-spectrum antiparasitic agent ivermectin has been very recently found to inhibit
SARS-CoV-2 in vitro and proposed as a candidate for drug repurposing in COVID-19. In the …

SARS-CoV-2 is a newly emerged coronavirus that causes a respiratory disease with
variable severity and fatal consequences. It was first reported in Wuhan and subsequently …

Ivermectin (IVM) is a broad-spectrum antiparasitic agent, having inhibitory potential against
wide range of viral infections. It has also been found to hamper SARS-CoV-2 replication in …

The current management of COVID-19 is mostly limited to general supportive care and
symptomatic treatment. Ivermectin is a broad-spectrum anti-parasitic drug used widely for …

Viral infections remain a major cause of economic loss with an unmet need for novel
therapeutic agents. Ivermectin is a putative antiviral compound; the proposed mechanism is …

Ivermectin is an FDA-approved broad-spectrum antiparasitic agent with demonstrated
antiviral activity against a number of DNA and RNA viruses, including severe acute …

Ivermectin is an FDA‐approved drug for a parasitic disease that has broad antiviral activity.
This study aims to analyse the efficacy of ivermectin in improving the Covid‐19 outcomes …

Ivermectin proposes many potentials effects to treat a range of diseases, with its
antimicrobial, antiviral, and anti-cancer properties as a wonder drug. It is highly effective …